CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Zen, Ke ^a   Liu, Dan Qing ^a   Guo, Ya Lan ^a   Wang, Chen ^a   Shan, Jun ^a   Fang, Ming ^b   Zhang, Chen Yu ^a   Liu, Yuan ^b  

^a NANJING UNIVERSITY   (China)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD44V4 ANTIGEN; COMPLEMENTARY DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIGAND; LYMPHOCYTE ANTIGEN; SIALYL LEWIS X ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CD44 PROTEIN, HUMAN; HERMES ANTIGEN;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL STRAIN MCF 7; CELL SURFACE; CHEMICAL LABELING; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS; MONOLAYER CULTURE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN VARIANT; UMBILICAL VEIN; BREAST TUMOR; CELL CULTURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; LIGANDS; NEOPLASM METASTASIS;

EID: 46649085669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001826     Document Type: Article

References (53)

1. Nubel T, Dippold W, Kleinert H, Kaina B, Fritz G (2004) Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. Faseb J 18: 140-142.
2. Laferriere J, Houle F, Hunt J (2002) Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann N Y Acad Sci 973: 562-572.
3. Laferriere J, Houle F, Taher MM, Valerie K, Huot J (2001) Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 276: 33762-33772.
4. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335.
5. Tozawa K, Okamoto T, Kawai N, Hashimoto Y, Hayashi Y, et al. (2005) Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma. Kidney Int 67: 1391-1396.
6. Koike T, Kimura N, Miyazaki K, Yabuta T, Kumamoto K, et al. (2004) Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A 101: 8132-8137.
7. Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM, et al. (1995) E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer 60: 426-431.
8. Moss MA, Zimmer S, Anderson KW (2000) Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Res 20: 1425-1433.
9. McEver RP (2002) P-selectin and PSGL-1: exploiting connections between inflammation and venous thrombosis. Thromb Haemost 87: 364-365.
10. Dimitroff CJ, Descheny L, Trujillo N, Kim R, Nguyen V, et al. (2005) Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65: 5750-5760.
11. Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R (2005) CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 65: 5812-5817.
12. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem 282: 3433-3441.
13. Bajorath J (2000) Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39: 103-111.
14. Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, et al. (2004) Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 173: 7594-7601.
15. Wang HS, Hung Y, Su CH, Peng ST, Guo YJ, et al. (2005) CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Exp Cell Res 304: 116-126.
16. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319.
17. Spessotto P, Rossi FM, Degan M, Di Francia R, Perris R, et al. (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol 158: 1133-1144.
18. Underhill C (1992) CD44: the hyaluronan receptor. J Cell Sci 103 (Pt 2): 293-298.
19. Mine S, Fujisaki T, Kawahara C, Tabata T, Iida T, et al. (2003) Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Exp Cell Res 288: 189-197.
20. Guo Y, Ma J, Wang J, Che X, Narula J, et al. (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561-1565.
21. Zahalka MA, Okon E, Gosslar U, Holzmann B, Naor D (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol 154: 5345-5355.
22. Lechertier T, Berard M, Vassy R, Herve MA, Crepin M (2004) Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes. Anticancer Res 24: 4011-4017.
23. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Quimron N, et al. (2005) A putative role for psoriasin in breast tumor progression. Cancer Res 65: 11326-11334.
24. Edberg DD, Adkins JN, Springer DL, Reeves R (2005) Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem 280: 8961-8973.
25. Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, et al. (2005) Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26: 1527-1535.
26. Tzircotis G, Thorne RF, Isacke CM (2005) Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci 118: 5119-5128.
27. Edwards DR, Murphy G (1998) Cancer. Proteases-invasion and more. Nature 394: 527-528.
28. Dumont N, Arteaga CL (2003) Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 3: 531-536.
29. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic, program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
30. Tremblay PL, Auger FA, Huot J (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25: 6563-6573.
31. Rosen SD, Bertozzi CR (1994) The selectins and their ligands. Curr Opin Cell Biol 6: 663-673.
32. Lauer-Fields JL, Malkar NB, Richet G, Drauz K, Fields GB (2003) Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation. J Biol Chem 278: 14321-14330.
33. Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116: 817-825.
34. Hibino S, Shibuya M, Hoffman MP, Engbring JA, Hossain R, et al. (2005) Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res 65: 10494-10501.
35. Fujimoto T, Kawashima H, Tanaka T, Hirose M, Toyama-Sorimachi N, et al. (2001) CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol 13: 359-366.
36. Marhaba R, Zoller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231.
37. Gotte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66: 10233-10237.
38. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, et al. (2005) CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 11: 3309-3314.
39. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217-226.
40. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, et al. (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443-455.
41. Wallach-Dayan SB, Grabovsky V, Moll J, Sleeman J, Herrlich P, et al. (2001) CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J Cell Sci 114: 3463-3477.
42. Herrera-Gayol A, Jothy S (1999) CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp Mol Pathol 66: 99-108.
43. Jensen PV, Larsson LI (2004) Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing. Histochem Cell Biol 121: 361-369.
44. Tzircotis G, Thorne RF, Isacke CM (2006) Directional sensing ofa phorbol ester gradient requires CD44 and is regulated by CD44 phosphorylation. Oncogene 25: 7401-7410.
45. Fanning A, Volkov Y, Freeley M, Kelleher D, Long A (2005) CD44 cross-linking induces protein kinase C-regulated migration of human T lymphocytes. Int Immunol 17: 449-458.
46. Fujisaki T, Tanaka Y, Fujii K, Mine S, Saito K, et al. (1999) CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59: 4427-4434.
47. Hession C, Osborn L, Goff D, Chi-Rosso G, Vassallo C, et al. (1990) Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions. Proc Natl Acad Sci U S A 87: 1673-1677.
48. Zen K, Babbin BA, Liu Y, Whelan JB, Nusrat A, et al. (2004) JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell 15: 3926-3937.
49. Zen K, Liu Y, Cairo D, Parkos CA (2002) CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. J Immunol 169: 5270-5278.
50. Price EA, Coombe DR, Murray JC (1996) Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer 65: 513-518.
51. Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, et al. (2004) Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol 24: 864-870.
52. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, et al. (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106: 584-592.
53. Roetger A, Merschjann A, Dittmar T, Jackisch C, Barnekow A, et al. (1998) Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model. Am J Pathol 153: 1797-1806.